Doctor profile · Federal record
Dr. SAAKSHI KHATTRI, MD
Dermatology Physician (CMS: DERMATOLOGY) · Student in an Organized Health Care Education/Training Program · Rheumatology Physician · NEW YORK, NY
- NPI 1265677033
- Accepts Medicare
- 20 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5 E 98TH ST
NEW YORK, NY 100296501
(212) 659-9210 - Mailing address
-
1 GUSTAVE L LEVY PL, BOX 3000
NEW YORK, NY 100296504
Credentials & registration
- NPI registered
- December 2008 — 18 yrs on file
- Profile last updated
- June 27, 2019
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #277924
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265677033. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,102
Distinct HCPCS
10
Medicare allowed
$142,037
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 264 | 161 | $144 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 235 | 36 | $140 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 123 | 70 | $202 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 96 | 30 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 76 | 68 | $103 | |
17000 |
Destruction of precancer skin growth, 1 growth | 63 | 53 | $68 | |
96920 |
Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 55 | 12 | $181 | |
11102 |
Biopsy of related skin growth, first growth | 43 | 42 | $110 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 42 | 40 | $146 | |
17110 |
Destruction of skin growth, 1-14 growths | 23 | 22 | $133 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 6.1× the peer median.Open Payments
Industry payments received
All-time total
$653,427
Transactions
551
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 133 | $124,782.04 | |
| Janssen Biotech, Inc. | 86 | $107,538.60 | |
| UCB, Inc. | 53 | $94,844.48 | |
| Amgen Inc. | 54 | $62,822.92 | |
| Lilly USA, LLC | 68 | $51,842.61 | |
| E.R. Squibb & Sons, L.L.C. | 43 | $46,925.25 | |
| Regeneron Healthcare Solutions, Inc. | 35 | $43,408.69 | |
| Boehringer Ingelheim International GmbH | 10 | $38,079.49 | |
| Novartis Pharmaceuticals Corporation | 10 | $22,211.51 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $14,347.50 | |
| Eli Lilly and Company | 6 | $10,980.00 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $10,565.34 | |
| Arcutis Biotherapeutics, Inc. | 17 | $7,134.58 | |
| PFIZER INC. | 12 | $6,119.05 | |
| UCB SA | 1 | $4,500.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
782
Patients
310
Total drug cost
$1,241,008
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 108 | 52 | $2,984 |
| Mupirocin | Generic | 88 | 68 | $750 |
| Dupixent Pen (Dupilumab) | Brand | 73 | 12 | $278,927 |
| Triamcinolone Acetonide | Generic | 73 | 60 | $1,214 |
| Dupixent Syringe (Dupilumab) | Brand | 61 | 0 | $261,623 |
| Clobetasol Propionate | Generic | 58 | 37 | $3,923 |
| Methotrexate (Methotrexate Sodium) | Brand | 46 | 0 | $1,546 |
| Gammaked (Immune Globul G/Gly/Iga Avg 46) | Brand | 42 | 0 | $375,238 |
| Minoxidil | Generic | 40 | 12 | $795 |
| Hydroxychloroquine Sulfate | Generic | 39 | 11 | $2,292 |